Clinical

Dataset Information

0

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of irinotecan and capecitabine in treating patients who have solid tumors that have not responded to previous treatment.

DISEASE(S): Cancer

PROVIDER: 2003342 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
| 2005173 | ecrin-mdr-crc
Clinical Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
| 2002957 | ecrin-mdr-crc
Clinical Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
| 2004726 | ecrin-mdr-crc
Clinical Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
| 2004140 | ecrin-mdr-crc
Clinical Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer
| 2006418 | ecrin-mdr-crc
Clinical Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
| 2003602 | ecrin-mdr-crc
Clinical Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma
| 2004126 | ecrin-mdr-crc
Clinical Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
| 2005756 | ecrin-mdr-crc
Clinical Chemotherapy in Treating Patients With Solid Tumors
| 2002684 | ecrin-mdr-crc
Clinical NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2007222 | ecrin-mdr-crc